Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by PW Noble
M32 Effect of Pirfenidone on All-Cause Mortality (Acm) and Forced Vital Capacity (Fvc) in Idiopathic Pulmonary Fibrosis (Ipf) Patients With Low FVC and/or Low Dlco: Analysis of Pooled Data From Ascend and Capacity
Related publications
M29 FVC Decline Over 1 Year Predicts Mortality but Not Subsequent FVC Decline in Patients With Ipf
Prognostic Value of Forced Expiratory Volume in 1 Second/Forced Vital Capacity in Idiopathic Pulmonary Fibrosis
Chronic Respiratory Disease
Pulmonary
Respiratory Medicine
Body Mass Index—percent Forced Vital Capacity—respiratory Hospitalization: New Staging for Idiopathic Pulmonary Fibrosis Patients
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Idiopathic Pulmonary Fibrosis and Pirfenidone
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
M27 Effect of Pirfenidone on Breathlessness as Measured by the Ucsd-Sobq Score in Patients With Idiopathic Pulmonary Fibrosis (Ipf) With Moderate Lung Function Impairment
Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment
Respiratory Medicine
Pulmonary
Respiratory Medicine
